NO20043474L - Oralt dispersibel farmasoytisk piribedilsammensetning - Google Patents

Oralt dispersibel farmasoytisk piribedilsammensetning

Info

Publication number
NO20043474L
NO20043474L NO20043474A NO20043474A NO20043474L NO 20043474 L NO20043474 L NO 20043474L NO 20043474 A NO20043474 A NO 20043474A NO 20043474 A NO20043474 A NO 20043474A NO 20043474 L NO20043474 L NO 20043474L
Authority
NO
Norway
Prior art keywords
piribetil
composition
orally dispersible
dispersible pharmaceutical
pharmaceutical
Prior art date
Application number
NO20043474A
Other languages
English (en)
Inventor
Herve Rolland
Patrick Wuthrich
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20043474L publication Critical patent/NO20043474L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20043474A 2002-01-21 2004-08-20 Oralt dispersibel farmasoytisk piribedilsammensetning NO20043474L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200671A FR2834894B1 (fr) 2002-01-21 2002-01-21 Composition pharmaceutique orodispersible de piribedil
PCT/FR2003/000179 WO2003061661A1 (fr) 2002-01-21 2003-01-21 Composition pharmaceutic orodispersible de piribedil

Publications (1)

Publication Number Publication Date
NO20043474L true NO20043474L (no) 2004-08-20

Family

ID=27589523

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043474A NO20043474L (no) 2002-01-21 2004-08-20 Oralt dispersibel farmasoytisk piribedilsammensetning

Country Status (27)

Country Link
US (1) US20050085485A1 (no)
EP (1) EP1467737B1 (no)
JP (1) JP4500051B2 (no)
KR (1) KR100588223B1 (no)
CN (1) CN100352440C (no)
AR (1) AR038194A1 (no)
AT (1) ATE327758T1 (no)
AU (1) AU2003214326B2 (no)
BR (1) BR0306869A (no)
CA (1) CA2473152C (no)
CY (1) CY1105414T1 (no)
DE (1) DE60305642T2 (no)
DK (1) DK1467737T3 (no)
EA (1) EA007286B1 (no)
ES (1) ES2263959T3 (no)
FR (1) FR2834894B1 (no)
GE (1) GEP20063819B (no)
HK (1) HK1081110A1 (no)
MA (1) MA27098A1 (no)
MX (1) MXPA04007035A (no)
NO (1) NO20043474L (no)
NZ (1) NZ533820A (no)
PL (1) PL204939B1 (no)
PT (1) PT1467737E (no)
UA (1) UA78277C2 (no)
WO (1) WO2003061661A1 (no)
ZA (1) ZA200405008B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9597278B2 (en) 2008-11-13 2017-03-21 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
US9884082B2 (en) 2008-11-13 2018-02-06 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE575343A (no) * 1955-09-09
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
AT376147B (de) * 1980-12-15 1984-10-10 Gergely Gerhard Verfahren und vorrichtung zum granulieren eines pulvergemisches
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
JP3253127B2 (ja) * 1991-06-07 2002-02-04 帝國製薬株式会社 生理活性ポリペプチド含有製剤
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
JP3122141B2 (ja) * 1994-01-31 2001-01-09 山之内製薬株式会社 口腔内溶解型圧縮成型物及びその製造法
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
EP1007083A1 (en) * 1997-05-09 2000-06-14 Feronpatent Limited Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
JP2983973B1 (ja) * 1998-10-13 1999-11-29 大正薬品工業株式会社 口腔内速崩壊性固形製剤
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP2001058944A (ja) * 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
AU2001273496A1 (en) * 2000-07-24 2002-02-05 Boehringer Ingelheim Pharmaceuticals Inc. Apparatus and method for predicting the suitability of a substance for dry granulation by roller compaction using small sample sizes
EP1175899B1 (fr) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granules à base d'amidon et de lactose
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
ZA200405008B (en) 2005-08-31
CN1688313A (zh) 2005-10-26
DK1467737T3 (da) 2006-09-18
EP1467737A1 (fr) 2004-10-20
AU2003214326B2 (en) 2007-08-02
JP2005529068A (ja) 2005-09-29
NZ533820A (en) 2005-08-26
UA78277C2 (en) 2007-03-15
CN100352440C (zh) 2007-12-05
EA007286B1 (ru) 2006-08-25
ATE327758T1 (de) 2006-06-15
PT1467737E (pt) 2006-08-31
FR2834894A1 (fr) 2003-07-25
PL370168A1 (en) 2005-05-16
EA200400885A1 (ru) 2004-12-30
AR038194A1 (es) 2005-01-05
DE60305642T2 (de) 2007-05-16
EP1467737B1 (fr) 2006-05-31
KR100588223B1 (ko) 2006-06-12
HK1081110A1 (en) 2006-05-12
ES2263959T3 (es) 2006-12-16
GEP20063819B (en) 2006-05-10
FR2834894B1 (fr) 2004-02-27
CA2473152A1 (fr) 2003-07-31
WO2003061661A1 (fr) 2003-07-31
JP4500051B2 (ja) 2010-07-14
BR0306869A (pt) 2004-11-03
PL204939B1 (pl) 2010-02-26
US20050085485A1 (en) 2005-04-21
KR20040075098A (ko) 2004-08-26
DE60305642D1 (de) 2006-07-06
MXPA04007035A (es) 2004-10-11
CY1105414T1 (el) 2010-04-28
CA2473152C (fr) 2010-08-31
MA27098A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
DK1575618T3 (da) Dispergerbare farmaceutiske kombinationer
NO20052335D0 (no) Dispergerbare defracirox-tabletter
PT1501534E (pt) Formulacoes farmaceuticas
FI20011478A0 (fi) Farmaseuttinen koostumus
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
NO20033556L (no) Farmasöytiske formuleringer
NO20033384L (no) Farmasoytisk formulering
ITMI20010748A0 (it) Composizioni farmaceutiche
EE200300416A (et) Ravimvorm
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DK1837019T3 (da) Orale dispergerbare farmaceutiske sammensætninger
IS7051A (is) Lyfjasamsetningar
DK1587478T3 (da) Farmaceutisk sammensætning
NO20035627D0 (no) Farmasöytisk formulering
NO20026123L (no) Farmasöytiske sammensetninger
FI20022128A (fi) Farmaseuttinen koostumus
NO20031095D0 (no) Farmasöytiske sammensetninger
NO20043474L (no) Oralt dispersibel farmasoytisk piribedilsammensetning
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
NO20044164L (no) Farmasoytiske sammensetninger
EE200200689A (et) Ravimkoostised
SI1467737T1 (sl) Farmacevtski sestavek piribedila za dispergiranjev ustih
ITMI20020926A1 (it) Composizioni farmaceutiche riepitelizzanti
DOP2002000508A (es) Composición farmaceutica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application